LeMaitre Vascular, Inc. LMAT
NASDAQ · United States · Health Technology
$80.19-2.40 (-2.91%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
LeMaitre Vascular (LMAT) is drawing fresh attention after its shares closed at US$80.58, with recent returns showing modest gains over the past month and a decline over the past 3 months. Viewed over a longer stretch, LeMaitre Vascular’s 1 year total shareholder return is down 7.29%, even as the 3 year total shareholder return of 54.81% and 5 year total shareholder return of 56.88% point to earlier strength that has cooled with the recent 90 day share price pullback of 14.21% from current...
LeMaitre Vascular has delivered a 56.9% share price gain over the past five years, yet its recent flat patch raises a simple question for you as an investor. Are the cash flows from this medical device business strong and reliable enough to support where the stock trades today? That 56.9% move over five years puts real weight on whether LeMaitre Vascular's cash generation can support the value the market now assigns to the business. The company focuses on vascular devices that can support...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.